These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28784612)

  • 1. Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function.
    Hauck PM; Wolf ER; Olivos DJ; Batuello CN; McElyea KC; McAtarsney CP; Cournoyer RM; Sandusky GE; Mayo LD
    Mol Cancer Res; 2017 Nov; 15(11):1598-1607. PubMed ID: 28784612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.
    Gao C; Xiao G; Piersigilli A; Gou J; Ogunwobi O; Bargonetti J
    Breast Cancer Res; 2019 Jan; 21(1):5. PubMed ID: 30642351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model.
    Tonsing-Carter E; Bailey BJ; Saadatzadeh MR; Ding J; Wang H; Sinn AL; Peterman KM; Spragins TK; Silver JM; Sprouse AA; Georgiadis TM; Gunter TZ; Long EC; Minto RE; Marchal CC; Batuello CN; Safa AR; Hanenberg H; Territo PR; Sandusky GE; Mayo LD; Eischen CM; Shannon HE; Pollok KE
    Mol Cancer Ther; 2015 Dec; 14(12):2850-63. PubMed ID: 26494859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircFSCN1 induces tumor progression and triggers epithelial-mesenchymal transition in bladder cancer through augmentation of MDM2-mediated p53 silencing.
    Deng W; Chen R; Xiong S; Nie J; Yang H; Jiang M; Hu B; Liu X; Fu B
    Cell Signal; 2024 Feb; 114():110982. PubMed ID: 37981069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
    Fan Y; Li M; Ma K; Hu Y; Jing J; Shi Y; Li E; Dong D
    Cancer Biol Ther; 2019; 20(5):617-632. PubMed ID: 30462562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation.
    Lin TY; Hsu HY
    Cancer Lett; 2016 Jun; 375(2):340-348. PubMed ID: 26992741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J
    Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
    Liu K; Xue B; Bai G; Zhang W
    Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
    Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
    J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia‑induced internalization of connexin 26 and connexin 43 in pulmonary epithelial cells is involved in the occurrence of non‑small cell lung cancer via the P53/MDM2 signaling pathway.
    Zeng SG; Lin X; Liu JC; Zhou J
    Int J Oncol; 2019 Oct; 55(4):845-859. PubMed ID: 31485592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
    PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
    Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
    Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
    Brekman A; Singh KE; Polotskaia A; Kundu N; Bargonetti J
    Breast Cancer Res; 2011 Jan; 13(1):R3. PubMed ID: 21223569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
    Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
    Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells.
    Chen Y; Wang DD; Wu YP; Su D; Zhou TY; Gai RH; Fu YY; Zheng L; He QJ; Zhu H; Yang B
    Br J Cancer; 2017 Oct; 117(8):1192-1201. PubMed ID: 28817834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
    Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
    Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.